Business Description

Description
Regado Biosciences Inc was incorporated in Delaware under the name Quartet Biosciences, Inc. in December 2001 and changed its name to Regado Biosciences, Inc. in March 2003. It is a biopharmaceutical company. The Company is engaged in the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular indications. The Company's product candidates consists of a two-component system: an aptamer and its specific active control agent. The aptamer is administered first and achieves its therapeutic effect within minutes. When the therapeutic effect of the aptamer is no longer needed, the control agent is administered to rapidly and precisely reduce or eliminate it. The level of reduction is determined by the amount of control agent given compared to the aptamer dose. The Company's product candidate, REG1, consists of pegnivacogin, a highly potent and selective anticoagulant, and anivamersen, its specific active control agent. The Company is developing REG1 as an anticoagulant for use in patients with cardiovascular conditions undergoing percutaneous coronary intervention, or PCI, a hospital-based procedure used to mechanically open or widen obstructed coronary arteries.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 2.68
Equity-to-Asset 0.44
Debt-to-Equity 0.77
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.57
Distress
Grey
Safe

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.5
Quick Ratio 3.5

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 100
Operating Margin % -5164.21
Net Margin % -4906.61
ROE % -140.29
ROA % -88.6
ROC (Joel Greenblatt) % -15238.86

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 678.87
PB Ratio 40.09
EV-to-Revenue 658.09
Earnings Yield (Greenblatt) % -7.85
FCF Yield % -4.67

Financials

RGDO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RGDO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Regado Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -205.74
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 583.2 - 5365.45
Shares Outstanding (Mil) 0.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Regado Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Regado Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Regado Biosciences Inc Frequently Asked Questions

What is Regado Biosciences Inc(RGDO)'s stock price today?
The current price of RGDO is $0.00. The 52 week high of RGDO is $5365.45 and 52 week low is $583.20.
When is next earnings date of Regado Biosciences Inc(RGDO)?
The next earnings date of Regado Biosciences Inc(RGDO) is .
Does Regado Biosciences Inc(RGDO) pay dividends? If so, how much?
Regado Biosciences Inc(RGDO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1